About rocuronium bromide
Non-depolarizing neuromuscular blocker
Used for
- Relaxes muscles during surgery under general anaesthesia
- Helps place a breathing tube
- May support mechanical ventilation in intensive care
Usual adult dose
Dose varies by procedure and clinical setting; given intravenously by an anaesthesia professional, typically 0.6 mg/kg for intubation.
Usual dose in children
Used in children under specialist supervision; dose is based on body weight and clinical setting.
Common side effects
- Prolonged muscle weakness or paralysis
- Low blood pressure or changes in heart rate
- Injection-site pain or swelling
- Rare severe allergic reaction
Important warnings
- Causes paralysis, including of breathing muscles; ventilation and monitoring are essential.
- Does not cause unconsciousness or relieve pain; anaesthesia or sedation is also required.
- Effects may last longer with liver or kidney disease, older age, or certain medicines.
- Use only by trained clinicians with resuscitation equipment available.
Pregnancy
Use only when clinically necessary; pregnancy-specific evidence is limited. A clinician should assess risks and benefits.
Breastfeeding
There is limited information; ask a clinician. The medicine is expected to have low transfer into milk due to its properties.
Interactions
- Some anaesthetics can prolong its muscle-relaxing effect.
- Certain antibiotics, magnesium, and lithium may increase or prolong paralysis.
- Some seizure medicines may reduce its effect or alter its duration.
- Other neuromuscular blockers can change its effects.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.